Jessamy is currently the General Manager, UK & Ireland for Sanofi’s General Medicines Global Business Unit, working alongside healthcare systems to deliver improved health for patients with chronic conditions, such as Diabetes and Cardiovascular disease.
Jessamy began her career in healthcare research/health economics following herBSc. (Hons) in Health Sciences/Health Economics from University of Aberdeen.Since then, she has worked in roles that span the pharmaceutical industry, academia and the NHS.
Jessamy’s most recent role was Director of Market Access, UKIE, supporting national and local healthcare access for patients to Sanofi medicines and vaccines. Prior to joining Sanofi in February 2015, she worked at Eli Lilly as Director, Real World Evidence (Australia, Canada, Europe) and previously as Director, Market Access Strategy (Australia, Canada, Europe). She has also held the post of Director, Health Technology Appraisal (Australia, Canada, EU, Japan) at Eli Lilly.
Jessamy has held Non-Executive Director Board level roles in the NHS for more than 10 years, the most recent being Non-Executive Adviser for Hampshire and Isle of Wight Partnership, North Hants Clinical Commissioning Group, previously a Non-Executive Director at the Isle of Wight Healthcare NHS Trust, and also worked as Executive Director on the Trust Board of an NHS Foundation Trust.